Novacyt SA convenes its Annual General Meeting

Novacyt SA, a company specializing in molecular diagnostics, announces that its Annual General Meeting will be held on June 30, 2026, at the Hilton Hotel, Paris Charles de Gaulle Airport. This meeting will be held in person. A webinar in English, hosted by Lyn Rees, Chief Executive Officer, and Steve Gibson, Chief Financial Officer, will also be offered to investors via the Investor Meet Company platform. French subtitles will be available. Interested investors can register online. Those already registered on the platform will be automatically invited.

For more details, investors are directed to Novacyt's website and its contacts through various financial partners such as SP Angel Corporate Finance LLP and Singer Capital Markets. The company emphasizes proactive communication with its investors using multiple channels.